AMIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Autonomix Medical, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.65−0.20 (-6.85%)
Close on Oct 19, 2026
- Market cap
- $1.44M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$21.08 (−88.83%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Autonomix Medical, Inc. reported revenue of $0 for the twelve months to Jun 30, 2026. Free cash flow was -$12.29M.
Revenue
$0
TTM Q1 2027
Operating income
-$16.38M
TTM Q1 2027
Free cash flow
-$12.29M
FY2026
EPS, diluted
-$6.99
TTM Q1 2027
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.44M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.46
- Dividend yield
- –
- Free cash flow yield
- -853.16%
Fundamentals
- Revenue
- $0
- Net income
- -$16.11M
- EPS, diluted
- -$6.99
- Free cash flow
- -$12.29M
- Book value per share
- $5.82
- Diluted shares
- 1M
Five years at a glance
Fiscal years 2022 to 2026 and trailing twelve months, USD
Revenue
$0
Operating income
-$16.38M
Net income
-$16.11M
EPS, diluted
-$6.99
Free cash flow
–
Reported periodTrailing twelve months